Jie Zhang

Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma.

Lucio Tentori, Carlo Leonetti, Marco Scarsella et al. · PubMed · 2003 · 204 citations

<i>In vitro</i> and <i>In vivo</i> Radiosensitization of Glioblastoma Cells by the Poly (ADP-Ribose) Polymerase Inhibitor E7016

Andrea Russo, Hyuk‐Chan Kwon, William Burgan et al. · Clinical Cancer Research · 2009 · 165 citations · Full text

Poly(ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis

Lucio Tentori, Pedro Miguel Lacal, Alessia Muzi et al. · European Journal of Cancer · 2007 · 146 citations

Angiogenesis, Natural Sciences, Pathology +5

Pharmacologic Inhibition of Poly(ADP-Ribose) Polymerase Is Neuroprotective Following Traumatic Brain Injury in Rats

Michelle C. LaPlaca, Jie Zhang, Ramesh Raghupathi et al. · Journal of Neurotrauma · 2001 · 128 citations

Traumatic Brain Injury, Pharmacologic Inhibition, Cell Death +16

Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of the Poly(ADP-ribose) Polymerase (PARP) Inhibitor Veliparib (ABT-888) in Combination with Irinotecan in Patients with Advanced Solid Tumors

Patricia LoRusso, Jing Li, Angelika M. Burger et al. · Clinical Cancer Research · 2016 · 108 citations · Full text